The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to neuromodulation company representatives.
Study Type
OBSERVATIONAL
Enrollment
39
Company representatives are questioned about three aspects: 1) goals in treating patients with neuromodulation for pain, 2) factors that respondents expect to change according to neuromodulation for pain and 3) their definition of success of neuromodulation for pain.
Vrije Universiteit Brussel
Jette, Belgium
Goals of company representatives, evaluated with a self-constructed question.
Goals of company representatives to treat patients with neuromodulation for pain.
Time frame: Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.
Company representatives expectations, evaluated with a self-constructed question.
Factors that respondents expect to change according to neuromodulation for pain.
Time frame: Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.
Company representatives definition of success of neuromodulation for pain, evaluated with a self-constructed question.
Company representatives their definition of success of neuromodulation for pain.
Time frame: Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.